Golden Seeds — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
EliseAI applies artificial intelligence to streamline operations in housing and healthcare, two industries historically resistant to technological transformation.
AI & Machine LearningEnterprise SoftwareHealthtechPropTechSaaSNew York, US
Minna Song(Co-founder and CEO)inStoyan Stoyanov(Executive Officer, Director)inAndrew Korn(Executive Officer)inKamil Sindi(Director)
BoardLouis Schotsky(Director)inJo Ann Corkran(Director)in
Co-investorsAlpha PartnersAndreessen HorowitzBessemer Venture PartnersFounders Circle CapitalGray Line PartnersGround Up Ventures+6 more
Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures.
BiotechHealthtechMedical DevicesNew MaterialsMontclair, US
Piyush M.(Founder)inWeiliam Chen(Director)James R. Pastena(Director)John M. Abrahams(Director)Richard Russo(Executive Officer, Director)Richard Olson(Director)
Co-investorsCentral Texas Angel NetworkHouston Angel NetworkKeiretsu Forum
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.